Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07770802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07770802 · ClinicalTrials.gov record · last posted 2026-08-18

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

Name: Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer — clinical trial record (NCT07770802)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorQingdao Sino-Cell Biomedicine Co., Ltd.

Started2026-10

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

A Single-Arm, Open-Label, Interventional Study to Evaluate the Efficacy of HS-IT101 Autologous Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy After Lymphodepleting Preconditioning with Fludarabine and Cyclophosphamide and Subsequent Interleukin-2 Therapy in Patients with Advanced Renal Cancer.

Trial Details

NCT Number	NCT07770802
Lead Sponsor	Qingdao Sino-Cell Biomedicine Co., Ltd.
Conditions	Clear Cell Renal Cell Carcinoma
Enrollment	15 participants
Start Date	2026-10
Primary Completion	2026-10 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-18